300
Participants
Start Date
Not specified
Primary Completion Date
January 31, 1992
Atovaquone
Sulfamethoxazole-Trimethoprim
Beth Israel Med Ctr / Peter Krueger Clinic, New York
Saint Vincent's Hosp and Med Ctr, New York
Harlem AIDS Treatment Group / Harlem Hosp Ctr, New York
Buckley Braffman Stern Med Associates, Philadelphia
Georgetown Univ Med Ctr, Washington D.C.
Veterans Administration Med Ctr, Washington D.C.
Natl Inst of Allergy & Infect Dis / Cln Ctr, Bethesda
Johns Hopkins Univ School of Medicine, Baltimore
Duke Univ Med Ctr, Durham
Dr Winkler Weinberg, Roswell
Univ of Alabama at Birmingham, Birmingham
Regional Med Ctr at Memphis, Memphis
The Regional Medical Ctr, Memphis, Memphis
Washington Univ School of Medicine, St Louis
Plaza Med Ctr, Houston
Baylor College of Medicine, Houston
USC, Los Angeles
Dr Richard Meyer, Los Angeles
UCLA CARE Ctr, Los Angeles
Kaiser Foundation Hosp, Harbor City
UCSF - San Francisco Gen Hosp, San Francisco
Dr Marcus Conant, San Francisco
Infectious Disease Med Group, Oakland
Univ of Cincinnati, Cincinnati
Univ of California / San Diego Treatment Ctr, San Diego
San Francisco Gen Hosp, San Francisco
Good Samaritan Hosp, Portland
CHU Saint Pierre, Brussels
Dr Julio S G Montaner, Vancouver
Wellesley Hosp, Toronto
Montreal Gen Hosp, Montreal
Hopital Bichat - Claude Bernard, Paris
August-Viktoria-Krankenhaus Chefarst derII Inneren Abteilung, Berlin
Universitat Munchen / Medizinische Poliklinik, Munich
Natac Med Centre, Amsterdam
Kobler Centre / Saint Stephen's Hosp, London
Saint Mary's Hosp, London
San Juan Veterans Administration Med Ctr, San Juan
Collaborators (1)
Glaxo Wellcome
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH